BioAdaptives (BioAdaptives) FCF Margin % : -1,300.00% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is BioAdaptives FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioAdaptives's Free Cash Flow for the three months ended in Dec. 2023 was $-0.09 Mil. BioAdaptives's Revenue for the three months ended in Dec. 2023 was $0.01 Mil. Therefore, BioAdaptives's FCF Margin % for the quarter that ended in Dec. 2023 was -1,300.00%.

As of today, BioAdaptives's current FCF Yield % is -38.25%.

The historical rank and industry rank for BioAdaptives's FCF Margin % or its related term are showing as below:

BDPT' s FCF Margin % Range Over the Past 10 Years
Min: -1680 Med: -795 Max: -668.75
Current: -796.43

During the past 9 years, the highest FCF Margin % of BioAdaptives was -668.75%. The lowest was -1680.00%. And the median was -795.00%.

BDPT's FCF Margin % is ranked worse than
98.55% of 1868 companies
in the Consumer Packaged Goods industry
Industry Median: 2.07 vs BDPT: -796.43

BioAdaptives FCF Margin % Historical Data

The historical data trend for BioAdaptives's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioAdaptives FCF Margin % Chart

BioAdaptives Annual Data

Trend

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,680.00

-668.75

-795.00

-1,335.29

-772.41

BioAdaptives Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-700.00	-633.33	-2,850.00	-350.00	-1,300.00

Competitive Comparison of BioAdaptives's FCF Margin %

For the Packaged Foods subindustry, BioAdaptives's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioAdaptives's FCF Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioAdaptives's FCF Margin % falls into.

BioAdaptives FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioAdaptives's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.224	/	0.029
	=	-772.41 %

BioAdaptives's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.091	/	0.007
	=	-1,300.00 %

BioAdaptives FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioAdaptives's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioAdaptives (BioAdaptives) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioAdaptives Inc (OTCPK:BDPT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128

Website

https://www.shopbioadaptives.com

BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. The human products are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; provide pain relief and healing; and improve overall emotional and physical wellness. Its product lines include PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore.

Executives

Richard Chiang	other: Previous Officer and Director	460 BRANNAN STREET SUITE 78064, SAN FRANCISCO CA 94107
Barry Epling	director	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Ferris Holding Inc.	10 percent owner	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Gerald Epling	director, officer: Pres, CEO, Secretary, CFO	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128